David J. Messenheimer

Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy

B. Fox, P. Newell, Shelly A Bambina, 2016, PloS one.

Future Research Goals in Immunotherapy.

B. Fox, Tyler Hulett, M. Afentoulis, 2019, Surgical oncology clinics of North America.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

Timing of PD-1 Blockade Is Critical to Effective Combination Immunotherapy with Anti-OX40

B. Fox, W. Urba, M. Afentoulis, 2017, Clinical Cancer Research.

Multispectral Imaging of T and B Cells in Murine Spleen and Tumor

Michael Neuberger, B. Fox, C. Bifulco, 2016, The Journal of Immunology.

Povetacicept, an Enhanced Dual APRIL/BAFF Antagonist That Modulates B Lymphocytes and Pathogenic Autoantibodies for the Treatment of Lupus and Other B Cell–Related Autoimmune Diseases

S. Dillon, S. Mudri, S. Peng, 2023, Arthritis & rheumatology.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .